Detalhe da pesquisa
1.
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts.
Blood
; 130(13): 1543-1552, 2017 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698205
2.
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.
Transfus Med Hemother
; 44(5): 292-300, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070974
3.
Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering.
Antibodies (Basel)
; 9(4)2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212776
4.
Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity.
Methods Mol Biol
; 1827: 381-397, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196508